Cargando…
A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation
BACKGROUND: Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying o...
Autores principales: | Tang, Jing, Huang, Zhi-Min, Chen, Ying-Yi, Zhang, Zhao-Hui, Liu, Gao-Lin, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338670/ https://www.ncbi.nlm.nih.gov/pubmed/22558448 http://dx.doi.org/10.1371/journal.pone.0036363 |
Ejemplares similares
-
Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay
por: Li, Jian, et al.
Publicado: (2006) -
Non-peptidic Cruzain Inhibitors with Trypanocidal Activity Discovered by Virtual Screening and In Vitro Assay
por: Wiggers, Helton J., et al.
Publicado: (2013) -
Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays
por: Wang, Ling, et al.
Publicado: (2016) -
Tyrosine Kinase Syk Non-Enzymatic Inhibitors and Potential Anti-Allergic Drug-Like Compounds Discovered by Virtual and In Vitro Screening
por: Villoutreix, Bruno O., et al.
Publicado: (2011) -
Ubiquitination Regulators Discovered by Virtual Screening for the Treatment of Cancer
por: Song, Ying-Qi, et al.
Publicado: (2021)